Therapeutics for Dengue: Recommendations for Design and Conduct of Early-Phase Clinical Trials
10.1371/journal.pntd.0001752
Saved in:
Main Authors: | Simmons C.P., Wolbers M., Nguyen M.N., Whitehorn J., Shi P.Y., Young P., Petric R., Nguyen V.V.C., Farrar J., Wills B. |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Format: | Article |
Published: |
2019
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/161645 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Subcutaneous infection with non-mouse adapted dengue virus D2Y98P strain induces systemic vascular leakage in AG129 mice
by: Tan, G.K.X., et al.
Published: (2016) -
Dengue haemorrhagic fever outbreak in Karachi, Pakistan, 1994
by: Chan, Y.C., et al.
Published: (2012) -
Pathogenesis and prevention of dengue virus infection: State-of-the-art
by: Tan, G.K., et al.
Published: (2011) -
Social and economic impact of dengue haemorhagic fever in Thailand
by: Santasiri Sornmani, et al.
Published: (2015) -
Chymase level is a predictive biomarker of dengue hemorrhagic fever in pediatric and adult patients
by: Rathore, Abhay P. S., et al.
Published: (2019)